Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Erosive pustular dermatosis of the scalp is a rare condition that causes scarring hair loss, mainly in older women, and requires ongoing treatment.

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

New effective scar treatments are urgently needed due to the current options' limited success.

Sensitive skin is often caused by nerve fibers and environmental factors, and can be managed with mild skincare and professional advice.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Early treatment helps stop hair loss in women of color.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

A gene in Sebekia benihana, CYP-sb21, is needed for a specific reaction on the drug Cyclosporine A, which could be important for hair growth without affecting the immune system.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Cyclosporin A promotes hair growth in mice and increases a protein linked to hair growth, but it may not work the same way in humans.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.